| Literature DB >> 28912723 |
Madeline Midgett1, Claudia S López1,2, Larry David3, Alina Maloyan4, Sandra Rugonyi1.
Abstract
Normal blood flow is essential for proper heart formation during embryonic development, as abnormal hemodynamic load (blood pressure and shear stress) results in cardiac defects seen in congenital heart disease (CHD). However, the detrimental remodeling processes that relate altered blood flow to cardiac malformation and defects remain unclear. Heart development is a finely orchestrated process with rapid transformations that occur at the tissue, cell, and subcellular levels. Myocardial cells play an essential role in cardiac tissue maturation by aligning in the direction of stretch and increasing the number of contractile units as hemodynamic load increases throughout development. This study elucidates the early effects of altered blood flow on myofibril and mitochondrial configuration in the outflow tract myocardium in vivo. Outflow tract banding was used to increase hemodynamic load in the chicken embryo heart between Hamburger and Hamilton stages 18 and 24 (~24 h during tubular heart stages). 3D focused ion beam scanning electron microscopy analysis determined that increased hemodynamic load induced changes in the developing myocardium, characterized by thicker myofibril bundles that were more disbursed in circumferential orientation, and mitochondria that organized in large clusters around the nucleus. Proteomic mass-spectrometry analysis quantified altered protein composition after banding that is consistent with altered myofibril thin filament assembly and function, and mitochondrial maintenance and organization. Additionally, pathway analysis of the proteomics data identified possible activation of signaling pathways in response to banding, including the renin-angiotensin system (RAS). Imaging and proteomic data combined indicate that myofibril and mitochondrial arrangement in early embryonic stages is a critical developmental process that when disturbed by altered blood flow may contribute to cardiac malformation and defects.Entities:
Keywords: cardiac development; congenital heart disease; embryonic myocardial maturation; hemodynamic regulation of heart development; hemodynamically-induced cardiac remodeling; outflow tract development
Year: 2017 PMID: 28912723 PMCID: PMC5582297 DOI: 10.3389/fphys.2017.00631
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Schematics of myofibril bundle orientation quantification. (A) Angles ϕ and θ were measured for each bundle. (A) ϕ and θ are the angles of the fibril bundle in the xy and xz planes in the sample volume, respectively. (B) ϕ and θ describe the bundle orientation in the circumferential and radial planes of the outflow tract, respectively.
Figure 2Example FIB-SEM image showing myofibrils in control outflow tract myocardium tissue. Several myofibril orientations are displayed, where the tissue mostly consisted of longitudinally oriented bundles arranged circumferentially around the outflow tract (A) compared to less frequent radially oriented bundles (B). The majority of z-bands only had a single myofibril bundle extending from either side (C), however, samples also contained a few examples of an immature configuration where 3 or more fibril bundles radiated from the same z-band center (D), as numbered above. Most myofibrils inserted into intercalated disks at nearly right angles as they do in mature tissue (E), while some oblique insertions were still visible in control tissue (F). Scale bar = 1 μm.
Figure 3Example FIB-SEM image showing mitochondria among myofibrils in control outflow tract myocardium tissue. Myofibrils are arranged in both circumferential and radial orientations. Mc, mitochondria; mf, myofibril. Scale bar = 5 μm.
Figure 4FIB-SEM organelle volume quantitation summary. Example 3D myocardium segmentation reconstructions from a control (A) and banded (B) embryonic heart with myofibril, mitochondrial, nuclear, and extracellular material displayed in green, blue, red, and black, respectively. (C) Average cellular volume fraction quantification from 3D reconstructions (n = 3 per group), where there were no significant differences of any cellular component between banded and control samples. Scale bar = 2 μm.
Figure 5Example myofibril bundle orientation display where each bundle is shown colored based on the orientation in the xy and xz planes for a control (A) and a banded (B) embryo. (C) Example myofibril bundle orientation angle histograms for a control and banded embryo. Scale bar = 2 μm.
Figure 6Example FIB-SEM images from a control (A) and a banded (B) embryo, with example bundle thickness measurement lengths at z-bands shown in orange. (C) Bundle thickness quantification box plots displaying the average, with boxes that mark the upper and lower quartiles and whiskers that mark the maximum and minimum values. The asterisk designates a significantly higher bundle thickness average in banded samples compared to controls (p < 0.05, n = 3). Scale bar = 1 μm.
Figure 7Volcano plot of proteomics data, depicting protein data p-values vs. fold change (FC). Red points represent data points with p < 0.05 and a fold rate >1.2; proteins associated with these points are listed in the supplementary file “Data Sheet 3.”
Figure 8Fold changes in mass-spectrometry measured protein abundances in banded samples compared to controls. Proteins associated with myofibril and mitochondrial proteins are shown, with positive and negative fold changes representing protein upregulation and downregulation, respectively. Protein abbreviations are listed in Tables 1, 2.
Myocardial contractile proteins.
| Myosin, heavy chain 11, smooth muscle (MYH11) | +1.5 | 0.04 | Contractile protein of smooth muscle cells (England and Loughna, |
| Tropomyosin 3 (TPM3) | +1.4 | 0.03 | Member of the tropomyosin family of actin-binding proteins that are central to the control of calcium-regulated thin filament function and striated muscle contraction (Rajan et al., |
| Leiomodin 2 (LMOD2) | +1.4 | <0.01 | Actin-binding protein that promotes the regulation of striated muscle thin filament assembly (Tsukada et al., |
q-value: false discovery rate adjusted p-value.
Cardiac mitochondrial proteins.
| Clustered Mitochondria (CluA/CLU1) Homolog (CLUH) | +1.4 | <0.01 | mRNA-binding protein involved in proper cytoplasmic distribution and clustering of mitochondria, that plays a role in mitochondrial biogenesis (Zhu et al., |
| Mitofusin 1 (MFN1) | −1.2 | 0.08 | Essential protein required for mitochondrial fusion which affects mitochondrial morphology (Chen et al., |
| Cytochrome c oxidase subunit VIIa polypeptide 2 (COX7A2) | −1.3 | 0.03 | Terminal oxidative phosphorylation Protein complex that plays a role in the mitochondrial electron transport chain (Hüttemann et al., |
| Cytochrome c oxidase subunit IV isoform 1 (COX4I1) | −1.2 | 0.02 | |
| isovaleryl-CoA dehydrogenase (IVD) | −1.2 | 0.03 | Matrix enzyme that is important in mitochondrial fatty acid oxidation (Hale et al., |
| NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 9 (NDUFA9) | −1.2 | 0.03 | Protein in the inner mitochondrial membrane that is the first protein complex in the electron transport chain (Hu et al., |
| Translocase of outer mitochondrial membrane 70 (TOMM70) | −1.1 | 0.03 | Import receptor of the outer mitochondrial Membrane that helps mediate the transition of precursor proteins from ribosomes to mitochondria (Sokol et al., |
| Voltage-dependent anion channel 1 (VDAC1) | −1.2 | 0.01 | Channel that provides exchange of metabolites and ions Across the outer mitochondrial membranes that are necessary for electron transport (Das et al., |
| Solute carrier family 25, member 22 (SLC25A22) | −1.2 | 0.04 | Mitochondrial carrier protein that transports glutamate through the inner mitochondrial membrane (Walker and Runswick, |
| Solute carrier family 25, member 4 (SLC25A4) | −1.3 | 0.03 | Mitochondrial carrier protein that transports adenine nucleotides through the inner mitochondrial membrane (Walker and Runswick, |
| Mitochondnrial ribosomal protein L10 (MRPL10) | −1.2 | 0.03 | Mitochondrial ribosomal proteins are involved in mitochondrial translation, biogenesis, and maintenance and are critical for healthy mitochondrial function (Sylvester et al., |
| Mitochondnrial ribosomal protein L14 (MRPL14) | −1.2 | 0.03 | |
| Mitochondnrial ribosomal protein L16 (MRPL16) | −1.2 | 0.01 | |
| Mitochondnrial ribosomal protein L41 (MRPL41) | −1.2 | 0.04 | |
| Mitochondnrial ribosomal protein L53 (MRPL53) | −1.2 | 0.02 | |
| Mitochondnrial ribosomal protein S15 (MRPS15) | −1.2 | 0.04 | |
| Mitochondnrial ribosomal protein S23 (MRPS23) | −1.2 | 0.01 |
q-value, false discovery rate adjusted p-value.
Figure 9Significantly inhibited and activated pathways due to banding treatment, based on proteomics data. The analysis was performed in IPA, using data from proteins that changed abundance significantly (p < 0.1; 948 proteins included in the analysis), and considering information from all tissues/cell lines. Pathways plotted have p < 0.05 and z-score absolute value >2 (blue denotes inhibition and orange activation). The plotted ratio shows the ratio of the number of dysregulated molecules in our analysis data set that corresponded to the pathway, vs. the total number of molecules in the canonical pathway.